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Abstract
Background: Transcription initiation RNAs (tiRNAs) are nuclear localized 18 nucleotide RNAs derived from
sequences immediately downstream of RNA polymerase II (RNAPII) transcription start sites. Previous reports have
shown that tiRNAs are intimately correlated with gene expression, RNA polymerase II binding and behaviors, and
epigenetic marks associated with transcription initiation, but not elongation.
Results: In the present work, we show that tiRNAs are commonly found at genomic CCCTC-binding factor (CTCF)
binding sites in human and mouse, and that CTCF sites that colocalize with RNAPII are highly enriched for tiRNAs.
To directly investigate the relationship between tiRNAs and CTCF we examined tiRNAs originating near the intronic
CTCF binding site in the human tumor suppressor gene, p21 (cyclin-dependent kinase inhibitor 1A gene, also
known as CDKN1A). Inhibition of CTCF-proximal tiRNAs resulted in increased CTCF localization and increased p21
expression, while overexpression of CTCF-proximal tiRNA mimics decreased CTCF localization and p21 expression.
We also found that tiRNA-regulated CTCF binding influences the levels of trimethylated H3K27 at the alternate
upstream p21 promoter, and affects the levels of alternate p21 (p21
alt) transcripts. Extending these studies to
another randomly selected locus with conserved CTCF binding we found that depletion of tiRNA alters
nucleosome density proximal to sites of tiRNA biogenesis.
Conclusions: Taken together, these data suggest that tiRNAs modulate local epigenetic structure, which in turn
regulates CTCF localization.
Background
In addition to mRNAs, it is now clear that most eukar-
yotic genic loci generate a complex network of overlap-
ping short (<200) and long non-protein coding RNA
(ncRNA) species [1-3]. This growing catalog of ncRNAs
includes a host of small RNA (sRNA) transcripts proxi-
mal to transcription start sites (TSSs) [4], some of
which are capped [5] or associate with polycomb repres-
sive complex (PCR2) components [6,7]. We have
recently described a set of nuclear localized dominantly
18 nucleotide tiny RNAs that are generated from
regions immediately downstream of TSSs and conserved
across metazoa but absent in fungi and plants [8,9]. We
have previously suggested that these transcription initia-
tion RNAs (tiRNAs) may be connected to epigenetic
regulation in light of the fact that (i) they originate from
the same position relative to the +1 nucleosome in evo-
lutionarily distant animals, suggesting that expression of
tiRNAs is influenced by the position of the nucleosome,
or vice versa, (ii) they are intimately connected with
peaks of RNA polymerase II (RNAPII) binding and
levels of gene expression, and (iii) they are enriched
genome-wide at chromatin marks associated with the
activation, but not elongation, of transcription [4,8,9].
We have also observed that tiRNAs are enriched at sites
of CCCTC-binding factor (CTCF) [9], an enigmatic epi-
genetic regulator that has been recently dubbed ‘the
master weaver’ of the genome [10].
CTCF is a highly conserved zinc finger protein asso-
ciated with a diverse set of phenomena including epige-
netic insulation, imprinting and transcriptional
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to both positively and negatively regulate gene expres-
sion in a gene-specific and context-specific manner
[10,14]. A resolution to this apparent incongruity has
recently been proposed: CTCF does not directly influ-
ence the surrounding genes or transcriptional machin-
ery, but rather acts as a three-dimensional orchestrator
of chromatin architecture [10]. CTCF’s involvement in a
wide range of epigenetic phenomena appears to be the
secondary, but undoubtedly regulated, effects of its abil-
ity to form specific intrachromosomal and interchromo-
somal connections [10].
CTCF has been shown to regulate the expression of
several tumor suppressor genes, including p21 (informal
gene name for the cyclin-dependent kinase inhibitor 1A
gene, CDKN1A) [11,15] and p16 (INK4a), the latter by
insulating the promoter from silent-state histone modifi-
cations such as H3K27 trimethylation (H3K27me3) [16].
CTCF has also recently been shown to be involved in
t h ee p i g e n e t i cr e g u l a t i o no ffrataxin (FXN), a gene
mutated and silenced in Friedreich ataxia, which causes
progressive damage to the nervous system [17]. Loss of
CTCF binding in the 5’ untranslated region (UTR) of
FXN leads to a deficiency of the FXN transcript, an
increase in FXN antisense transcript 1,a n dh e t e r o c h r o -
matin formation involving the +1 nucleosome [17].
Given that tiRNAs and RNAPII are intimately con-
nected, and that there is increasing evidence that CTCF
and RNAPII are coupled together (see below) [18-22],
we speculated that tiRNAs at CTCF-binding sites might
be involved in the alteration of local chromatin states,
and therefore transcript expression, via indirect regula-
tion CTCF.
Results and discussion
We have previously shown that tiRNAs isolated from
THP-1 cells (a human monocytic leukemia cell line) are
systematically enriched at white blood cell CTCF bind-
ing sites [9]. To examine if this relationship is preserved
across cell and tissue types, and multiple species, we
interrogated small RNA enrichments at CTCF binding
sites in MCF-7 breast cancer cells and mouse embryonic
stem cells (mESCs) (for a full list of data sources please
see (Additional file 1, Table S1).
Consistent with prior work we found that tiRNAs
d e r i v e df r o mb o t hM C F - 7a n dm E S C sa r ee n r i c h e d
approximately sixfold at CTCF binding sites that sit out-
side TSSs or other annotated genomic features (see
Methods and Figure 1a), and show the characteristic 18
nucleotide tiRNA peak (Figure 1b, c). When CTCF
binding sites were further refined to include only sites
coincident with RNA polymerase II binding (CTCF-
RNAPII sites), tiRNA enrichments increased consider-
ably, to approximately 45-f o l d .I n d e e d ,m o r et h a n5 0 %
and 20% of MCF-7 and mESC CTCF-RNAPII sites
intersect with tiRNAs, respectively (Tables 1 and 2).
This relationship appears to bridge the reports indicat-
ing that tiRNA biogenesis is a direct result of RNAPII
backtracking and nascent transcript cleavage [4,8,9], and
recent studies showing that CTCF is directly involved in
RNAPII function. Indeed, it has now become clear that
(i) a subpopulation of CTCF directly interacts with the
large subunit of RNAPII through it’s phosphorylated C-
terminal tail [21,22], (ii) that in some cases a single
CTCF site is both necessary and sufficient to drive
RNAPII transcription in the absence of canonical pro-
moters by recruitment of RNAPII [21,22], and (iii) that
CTCF specificity for, and regulation of, transcriptionally
competent complexes also extends to RNA polymerase I
[18-20].
To examine if the association between tiRNAs, CTCF
and RNAPII extends beyond MCF-7 and mESCs we
identified CTCF sites conserved across an additional
eight human cell lines (GM12878, HepG2, HMEC,
HSMM, HUVEC, K562, NHEK, and NHLF cells) [23,24]
and RNAPII sites conserved across three (K562,
GM12878, and HUVEC), and intersected them with
nuclear and cytoplasmic small RNAs (sRNAs) from
THP-1 and 5-8f cells (a nasopharyngeal carcinoma cell
line [25]) and MCF-7 total sRNAs. Despite the fact that
these datasets are derived from disparate origins, nuclear
sRNAs from THP-1 and 5-8f are 33-fold and 16-fold
enriched, respectively, and total sRNAs from MCF cells
are 31-fold enriched at conserved CTCF-RNAPII sites
(Additional file 2, Figure S1a). Additionally, like the
MCF-7 and mESC datasets discussed above, the small
RNAs that overlap CTCF-RNAPII sites are dominantly
18 nucleotides, indicating they are tiRNAs (Additional
file 2, Figure S1b-d). Overall, greater than 10% of the
conserved CTCF sites, and 60% of conserved CTCF-
RNAPII sites, overlap with sequences that generate tiR-
NAs (Additional file 3, Table S2). To further ensure that
the tiRNA enrichment at CTCF-RNAPII sites was
robust we parsed the conserved human CTCF sites into
two groups by origin, ‘cancer’ and ‘normal’,a n d
removed all CTCF sites that overlapped with TSSs,
repeat masker annotationsa n ds m a l lR N A s .U s i n gt h e
most robust RNAPII datasets in each group (MCF-7
and HUVEC for ‘cancer’ and ‘normal’, respectively), we
f o u n dt h a tt h i sd r a m a t i c a l l yr e d u c e ds e ts t i l ls h o w s
robust enrichment for tiRNAs at CTCF-RNAPII sites
(Additional file 4, Figure S2).
To experimentally interrogate the tiRNA-CTCF-RNA-
PII relationship we queried for sites in clinically relevant
genes and identified a CTCF-RNAPII site with tiRNAs
in the first intron of p21, which is conserved across
both multiple human cell types (Figure 2) and mamma-
lian species (Additional file 5, Figure S3). CDKN1A/p21
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checkpoint to inhibit cell cycle progression [26-29], and
its downregulation (but not mutation) is a common fea-
ture of many cancers [30-34]. In addition to p21 mRNA,
the p21 locus encodes a number of other transcripts,
including alternative p21 transcripts (p21
alt)t h a to r i g i -
nate from a unique promoter located approximately 2
kb upstream of the canonical p21 transcription start site
and include the majority of the p21 coding regions in
their final spliced products [35], and a long non-coding
Figure 1 Enrichment of transcription initiation (ti)RNAs at CCCTC-binding factor-RNA polymerase II (CTCF-RNAPII) sites in human MCF-
7 and mouse embryonic stem (mES) cells. (a) Enrichment of tiRNAs at CTCF sites in MCF-7 and mES cells compared to 1,000 simulated
random distributions. (b, c) Size distribution of tiRNAs that intersect CTCF-RNAPII sites in MCF-7 and mES cells.
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states [36] (Figure 2).
The p21 locus encodes two tiRNA clusters, one at the
TSS (tss-tiRNAs) and the other at the CTCF-RNAPII
site (CTCF proximal (cp)-tiRNAs) that are antisense to
one another. The tss-tiRNAs are sense to the gene (as
observed generally), while the cp-tiRNAs are antisense.
Both overlap distinct peaks of RNAPII binding, suggest-
ing that their biogenesis is tied to RNAPII molecules
heading in opposite directions, possibly linked to
nucleosome position [4], and this reinforces our pre-
vious finding that tiRNAs aref o u n da ts i t e so fa c t i v e
RNAPII transcription initiation outside of canonical
transcription start sites (Figure 2).
To investigate the function of p21 tiRNAs, we utilized
short antisense ‘sponge’ RNAs [37] that were designed
to bind and inhibit tss-tiRNAs and cp-tiRNAs (Figure
2). MCF-7 cells transfected with the cp-tiRNA sponge
demonstrated a significant increase of p21 mRNA and
p21
alt expression, as measured by quantitative PCR
(qPCR) (Figure 3a, b). In contrast, the tss-tiRNA sponge
did not exhibit a detectable effect on p21 expression
(Figure 3a, b), and thus cp-tiRNAs became the focus of
the remainder of this study.
As reverse transcription in the qPCR samples was not
specifically primed (Figure 3a, b), these transcripts
might represent sense and/or antisense transcripts asso-
ciated with these regions [36] or any of the plethora of
splice variants. To determine the extent of the effect
that the cp-tiRNA sponge has on relative sense and anti-
sense p21 transcript levels, strand-specific reverse tran-
scription PCR (RT-PCR) was performed. Upon
treatment with the cp-tiRNA sponge, p21 mRNA, sense
p21
alt, and antisense p21
alt transcript levels increased,
whereas transcripts antisense to p21 mRNA were
unaffected (Figure 3c, d). These data indicate that
CTCF-proximal tiRNAs may be involved in the negative
regulation of p21.
We next performed the reciprocal experiment testing
the effect that overexpression of CTCF-proximal tiRNA
mimics has on p21 expression. Consistent with our
speculation that tiRNAs are connected to transcriptional
regulation, we found that overexpression of a set of four
cp-tiRNA mimics resulted in a marked reduction of the
p21 mRNA (Figure 3e). To confirm that the effect of
the cp-tiRNA sponges and mimics was not restricted to
MCF-7 cells we repeated these experiments in THP-1
cells and found that the principal results were recapita-
tulated (Additional file 6, Figure S4), indicating that cp-
tiRNAs have a regulatory effect on p21 transcription in
multiple human cell systems.
To further investigate the effects of cp-tiRNA sponge
and mimics on p21 transcription, elongating forms of
RNAPII were assessed by chromatin immunoprecipita-
tion-PCR (ChIP-PCR). The only signal increase
appeared in regions overlapping p21
alt, although that
increase was modest (Figure 4), suggesting that cp-tiR-
NAs do not function by affecting local RNAPII densities,
but rather by directly or indirectly modulating local
chromatin architecture.
To explore this possibility we examined the effects of
cp-tiRNAs sponge and mimic constructs on CTCF
localization, and on epigenetic marks at various loca-
tions within the p21 locus by ChIP. The density of the
silent state chromatin mark, H3K27me3, did not
change upon introduction of cp-tiRNA sponge or
mimic constructs at their perfectly complementary tar-
get sites (that is, at sites of tiRNA biogenesis; Figure
5a, b), as would be expected if the cp-tiRNA mimic or
sponges were themselves altering local chromatin
Table 1 MCF-7 CCCTC-binding factor (CTCF), RNA polymerase II (RNAPII) and CTCF-RNAPII site intersections with small
RNAs (sRNAs)
Total number of MCF-7 sites Number that overlap with sRNAs (%) Total number of sRNAs overlapped
(percentage total sRNAs)
RNAPII 10,821 1,165 (11) 2,333 (2)
CTCF 23,857 2,047 (9) 4,731 (4)
CTCF + RNAPII 936 468 (50) 1,609 (1.6)
Table 2 Mouse embryonic stem (mES) CCCTC-binding factor (CTCF), RNA polymerase II (RNAPII) and CTCF-RNAPII site
intersections with small RNAs (sRNAs)
Total number of mES sites Number that overlap with sRNAs (%) Total number of sRNAs overlapped
(percentage total sRNAs)
RNAPII 8,421 575 (7) 1,775 (3)
CTCF 13,469 589 (4) 981 (1.5)
CTCF + RNAPII 434 86 (20) 186 (0.3)
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coding RNAs associated with transcriptional gene
silencing [38]. However, H3K27me3 levels upstream of
the p21
alt transcription start site were decreased upon
cp-tiRNA sponge treatment (Figure 5c). Given that the
distance between the site of tiRNA biogenesis and the
p21
alt promoter is greater than 6 kilobases, we specu-
lated that these effects are facilitated by tiRNA-
mediated regulation of other epigenetic regulators cap-
able of acting at long distances.
Consistent with this, treatment with the cp-tiRNA
sponge resulted in a significant increase in CTCF
binding (Figure 5a), and overexpression of the cp-tiRNA
mimics exhibited a significant decrease of CTCF binding
(Figure 5b). This indicates that the effect of cp-tiRNAs
on p21 transcription is directly related to its ability to
modulate CTCF binding, which may be involved in
three-dimensional (re)ordering of the p21 locus. Indeed,
western blot analysis showed that p21 protein levels
were increased in samples treated with the cp-tiRNA
sponge, and decreased in samples treated with the cp-
tiRNA mimic constructs (Figure 5d, e). Taken together,
t h e s ed a t as u g g e s tt h a to n ef u n c t i o no fp21 cp-tiRNAs
may be to inhibit CTCF binding to the p21 gene,
Figure 2 Schematic depicting the p21 (cyclin-dependent kinase inhibitor 1A gene, also known as CDKN1A) locus. The blue lines, boxes
and arrows at the top of the image show the p21 and antisense transcripts. Small black boxes connected by black lines depict the five primer
pairs used in this study. THP-1 small RNAs (sRNAs) are shown as a density plot in red, followed below by RNA polymerase II (RNAPII) binding
from multiple cell types, and CCCTC-binding factor (CTCF) binding across eight cell types. The THP-1 nuclear sRNA deep sequencing data is the
deepest sRNA dataset currently available and was therefore, given the conservation of the CTCF site, was used as the basis for the sponge and
mimic constructs in all cell lines.
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Page 5 of 13Figure 3 The effects of transcription initiation (ti)RNA sponges and mimics on p21 (cyclin-dependent kinase inhibitor 1A gene, also
known as CDKN1A) expression. (a) Transfection by the CCCTC-binding factor (CTCF) proximal (cp)-tiRNA sponge resulted in an increase in p21
mRNA and (b) p21
alt transcript levels. Reverse transcription was non-specifically primed and cDNA was analyzed by quantitative (qPCR) using
primer set 2 for p21 mRNA and primer set 1 for p21
alt RNA. (c) Further validation of the results in (a) and (b) were confirmed by transfection
with the cp-tiRNA sponge followed by strand-specific quantitative reverse transcription (qRT)-PCR which showed an increase in both antisense
and sense p21
alt transcript levels, and (d) an increase in sense p21 mRNA. (e) Transfection of cp-tiRNA mimics resulted in a decrease in both
sense classical and alternate p21 transcripts. (a-e) Samples were analyzed at 72 h post transfection. The averages of samples transfected in
triplicate are shown, error bars represent the standard errors of the means, and P values from paired t tests are shown.
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stream translation.
To test whether cp-tiRNAs can modulate CTCF bind-
ing at other loci we generated sponges for cp-tiRNAs
derived from an intergenic region downstream of the
C2orf42 (Homo sapiens chromosome 2 open reading
frame 42), and an intergenic site upstream of StAR-
related lipid transfer domain containing 13 (STARD13)
(Additional file 7, Figure S5). To ensure that selection
bias did not affect our study, these sites were chosen at
random from approximately 900 sites with strong CTCF
binding and tiRNA conservation across cell lines (see
Methods). Examination of the C2orf42 site revealed no
significant effect of tiRNA sponges (Additional file 8,
Figure S6). However, we observed that STARD13 cp-
tiRNA sponges resulted in a reduction in STARD13
mRNA expression, in spite of the fact that CTCF bind-
ing was largely unaffected (Figure 6a, b). This cp-tiRNA-
mediated sponge effect is contrary to that observed for
p21, which strongly increased p21 expression. To
further investigate this we examined local nucleosome
density at both loci and found that the p21 cp-tiRNA
sponges induced increased nucleosomal localization,
while the STARD13 cp-tiRNA induced a decrease in
nucleosomal localization (Figure 6c). This is consistent
with our hypothesis that cp-tiRNAs mimics and sponges
facilitate condition dependent small-scale rearrange-
ments to nucleosome order, and that this in turn leads
to large-scale chromatin reorganization orchestrated by
CTCF or other DNA binding and chromatin modifying
complexes. Indeed, recent work has shown that an array
of up to 20 well positioned nucleosomes enriched for
the transcription initiation mark H3K4me3 flank CTCF
sites, a phenomenon previously only observed down-
stream of TSSs [39]. This finding not only potentially
explains why tiRNAs are frequently found at CTCF
sites, but also suggests that the contradictory p21 and
STARD13 tiRNA sponge effects may result from
changes to the local density of chromatin activating
marks (Figure 7).
Figure 4 RNA polymerase II (RNAPII) response to the p21 (cyclin-dependent kinase inhibitor 1A gene, also known as CDKN1A) CCCTC-
binding factor (CTCF) proximal (cp)-transcription initiation (ti)RNA sponge. Active RNAPII enrichment sites in the p21 (CDKN1A) locus were
determined by chromatin immunoprecipitation (ChIP). RNAPII levels are generally unaffected, although a modest increase in RNAPII activity
downstream of the p21
alt transcription start site was observed.
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Page 7 of 13Figure 5 CCCTC-binding factor (CTCF) binding and H3K27 trimethylation (H3K27me3) at p21 (cyclin-dependent kinase inhibitor 1A
gene, also known as CDKN1A) in response to the CTCF proximal (cp)-transcription initiation (ti)RNA sponge and mimics. (a)
Transfection with the cp-tiRNA sponge resulted in an enrichment of CTCF at the conserved CTCF binding site. H3K27me3 was unaffected at the
canonical p21 promoter or in the p21-coding region. (b) Transfection with cp-tiRNA mimics resulted in a decrease of CTCF at the CTCF binding
site. H3K27me3 was generally unaffected. (c) Transfection with the cp-tiRNA sponge resulted in a decrease of H3K27me3 at the alternate p21
promoter, consistent with an increase in transcriptional activity. (d) As measured by western blot, samples transfected with the cp-tiRNA sponge
showed an increase of p21 protein levels, while samples transfected with the cp-tiRNA mimics showed a decrease. (e) Differences in p21 protein
levels from the western blot in (d) quantified using ImageJ. (a-d) Samples were analyzed as indicated 72 h post transfection. No antibody values
were subtracted from each immunoprecipitation, and the resultant values were standardized to the input each sample. The averages of samples
transfected in triplicate are shown, error bars represent the standard errors of the means, and P values from paired t tests are shown.
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tion is unclear, although there are several obvious possi-
bilities: (i) cp-tiRNAs spanning the CTCF binding site
may coat local chromatin by binding nascent transcripts
[36] or chromatin associated RNAs [40-42], which could
sterically hinder CTCF from accessing its binding site;
(ii) cp-tiRNAs may directly interact with CTCF and
inhibit CTCF binding, although attempts to immunopre-
cipitate CTCF with biotin-linked cp-tiRNAs were unsuc-
cessful (data not shown); (iii) cp-tiRNAs may bind to
regulatory elements including cis-acting ncRNAs (for
example, bx332409 at p21) or polycomb group compo-
nents and direct their action to specific sites; or (iv) cp-
tiRNAs may serve as sequence-specific markers for
chromatin modification complexes.
Conclusions
The data presented here indicate that cp-tiRNAs can
have a powerful effect on CTCF binding and local tran-
scription. Indeed, tiRNA-mediated modulation of CTCF
binding at p21 not only reduces p21 mRNA and protein
levels, but also appears to affect chromatin state and
expression of p21
alt transcripts. This suggests that at
some loci the role of tiRNAs, whose biogenesis is con-
nected to RNAPII activity and progression, may be to
modulate (presumably indirectly) local chromatin states,
which in turn regulates the binding of other factors
including CTCF. Indeed, the relationship between
tiRNAs and epigenetic structures may indicate a self-
reinforcing feedback loop wherein the RNAPII-nucleo-
some interaction generates tiRNAs, which in turn serve
to mark (directly or indirectly) nucleosome positions
and/or epigenetic state. Although the mechanism of
tiRNA action is still elusive, this work is the first to
report a role for tiRNAs in gene regulation, and shows
that at least a subset of tiRNAs are functional modula-
tors of CTCF, which may lead to the development of
novel RNA-based therapeutics that target epigenetic reg-
ulation of gene structure and transcription.
Methods
Bioinformatic analyses
Bioinformatic analyses were performed on a local high-
performance computer at the UQ Institute for Molecu-
lar Bioscience that houses a mirror of the UCSC Gen-
ome Brower [43]. We used a suite of in-house AWK, C,
Perl, and Python scripts and UCSC backend tools. All
small RNA, CTCF binding and RNAPII binding data
were obtained from publicly available sources and are
listed in detail in Additional file 1, Table S1. For all
ChIP-seq datasets the available peak calls were used,
except in the case of the mES RNAPII data where peaks
were defined as regions with signal greater than 3 SDs
from the mean. All intersections were performed using
a modified version of the UCSC backend tools bedInter-
sect or overlapSelect. A minimum of 1 bp of overlap
Figure 6 The effect of a CCCTC-binding factor (CTCF) proximal (cp)-transcription initiation (ti)RNA sponge on StAR-related lipid
transfer domain containing 13 (STARD13). (a) The effect of the STARD13 sponge on CTCF at the CTCF binding site. (b) The effects the
STARD13 cp-tiRNA sponge on mRNA expression. Experiments were standardized to pCDNA transfected MCF-7 cells. (c) The effects of the p21
(cyclin-dependent kinase inhibitor 1A gene, also known as CDKN1A) cp-tiRNA and STARD13 tiRNA sponges on nucleosomal positioning based on
histone H3 localization. (a-c) Samples were analyzed as indicated 72 h post transfection. The averages of triplicate transfected samples are shown
with the error bars representative of the standard errors of the means, and P values from paired t tests. (a, c) No antibody values were
subtracted from each IP, and the resultant values were standardized to the input for each sample.
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intersected with another. The relative enrichment of
small RNAs at CTCF sites with or without RNAPII cov-
erage was computing using an in-house (Perl) bootstrap-
ping program over 1,000 iterations as previously
described [9]. Bootstrapping was constrained such that
the randomized placements of small RNAs excluded
TSSs, known small RNA annotations, repeat masker
annotations and genome assembly gaps. For the analysis
o ft h eM C F - 7 ,m E S ,a n dh u m a nC T C Fd a t ag r o u p e d
into ‘cancer’ and ‘normal’ the data was parsed so that
data points that intersected with known small RNA
annotations, the 500 bp adjacent to TSSs, repeat masker
annotations or Ensembl annotations less than 300
nucleotides were removed. The conserved CTCF site
data set were generated by taking all the peaks identified
by Broad/ENCODE as significant across all eight sources
(see Additional file 1, Table S1) and intersecting them
against one another using the UCSC backend tool over-
lapSelect. Overlapping CTCF features (called peaks)
were collapsed into one concordant set of coordinates
using the UCSC tool featureBits. Small RNA size distri-
butions were computed as previously described [9].
Cell culture and transfection
Experiments were conducted in MCF-7 and THP-1 cells
cultured at 37°C and 5% CO2 in Dulbecco’s modified
Eagle’s medium or RPMI 1640 (THP-1 cells only)
Figure 7 A schematic representation of transcription initiation (ti)RNA sponge effects on the p21 (cyclin-dependent kinase inhibitor
1A gene, also known as CDKN1A) and StAR-related lipid transfer domain containing 13 (STARD13) loci. (a) The p21 CCCTC-binding factor
(CTCF) proximal (cp)-tiRNA sponge removes tiRNAs from the system, which in turn facilitates increased CTCF binding and, consistent with the
literature, increased nucleosome ordering and density. CTCF-adjacent nucleosomes are known to be enriched for the H3K4 trimethylation
(H3K4me3) transcription activation mark. Here we speculate that the increased density of this mark may drive the increased p21 expression
observed in the presence of the cp-tiRNA sponge. (b) We observed little effect of the STARD13 sponge on CTCF density, but our results indicate
that the sponge nonetheless induces reduced nucleosome density and STARD13 expression. Here we propose that reduced levels or
concentrations of H3K4me3 marks due to the decrease in nucleosome density may modulate STARD13 expression. (a, b) Black, green and red
text indicates no change, increased levels or decreased levels, respectively.
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lin-streptomycin (Life Technologies, Carlsbad, Califor-
nia, USA). Plasmid transfections of MCF-7 cells were
performed using Lipofectamine 2000 (Life Technologies,
Carlsbad, California, USA) per the manufacturer’s guide-
lines at a concentration of 1 μg/1 × 10
6 cells. Plasmid
transfections of THP-1 cells were carried out using the
Neon electroporation system (Life Technologies, Carls-
bad, CA, USA), per manufacturer’s guidelines.
Sponge and mimic plasmid construction
Sponge plasmids: reverse complement sequences to the
promoter-proximal and CTCF-proximal tiRNA sites in
p21 were amplified from MCF-7 genomic DNA by poly-
merase chain reaction (PCR) using primers with BglII
restriction sites on either end (Additional file 3, Table
S2). Amplified DNA was digested by BglII and ligated
into the similarly cut pCDNA3 U6M2 plasmid. The par-
ent vector, pCDNA3 U6M2, was used as a control in
sponge experiments. The resulting sponge sequences
were: p21 promoter-proximal tiRNA sponge (pp-tiRNA)
5’CCGCCGGCCCGGGGTCCCCTGTTGTCTGCCGC-
CGCTCTCTCACCTCCTCTGAGTGCCTCGGT GCC
TCGGCGAATCCGCGCCCAGCTCCGGCTCCACAA
GGAACTGACTTCGGCAGCTGCTCACA CCTCAG
CTGG3’ and p21 CTCF-proximal tiRNA sponge (cp-
tiRNA) 5’GGGCTCAGGGCTTCCCGACCTAGCCCA-
GATTCCCTCTCCGAAAGCTACAGGGCTGAGCGGA
GCAGGGGGGCGAGTCGCCCCCTGGGGCGCCGCC
GCCTGGCGCGGACCACAGCGCGTCCTCT CCGTC
CCAAACCCCTGGGGGACACTTGCGCCCTCTTCGT-
GAGGAAAAGCATCTTGGAGCTGG GTTAGGAACT
TGGGGCGCCCAGGCAGCTTCCCCTCTCCTTGC
CTCCCTCCACGTCGCGTTTCT GGGAGGACTTGC-
GAGCGGTTTTGTTTTCGTTGCTCCCGTCTATTTT-
TATTTTCCAGGGATCTGA CT3’.
Sponge constructs for C2Orf41 and STARD13 were
constructed by annealing the respective oligonucleotides
together (Additional file 3, Table S2), top strand oligo
(200 μM): 5 μl bottom strand oligo (200 μM): 5 μl, 10 ×
Oligo Annealing Buffer (BLOCK-iT kit*, Life Technolo-
gies, Carlsbad, California, USA): 2 μl, DNase/RNase-free
water: 8 μl. The reaction was heated to 95°C for 4 min,
cooled to room temperature and treated to polynucleo-
tide kinase (PNK) (1 μl PNK (10,000 U/ml), 1 μlT 4
ligase buffer, 4 μld s O l i g o ,4μl water, at 37°C for 30
min). The oligonucleotides were purified using minelute
PCR purification kit and ligated to pCDNA3 U6M2 as
described above.
Mimic plasmids
A negative control and four sequences of CTCF-proxi-
mal tiRNAs were synthesized (Integrated DNA Technol-
ogies) and cloned into the BLOCK-iT U6 RNAi Entry
Vector (Life Technologies, Carlsbad, CA, USA) per
manufacturer’s guidelines. The mimics, four predomi-
nant cp-tiRNA sequences (Additional file 9, Table S3)
were independently cloned into the U6 driven BLOCK-
iT system (Life Technologies, Carlsbad, CA, USA). The
resultant plasmids were transfected into MCF-7 cells as
described previously [36].
Quantitative strand-specific PCR (qPCR)
RNA was extracted (RNeasy Qiacube, Qiagen), DNase
treated (TURBO DNase, Ambion), reverse transcribed
(Reverse Transcriptase Core Kit, Eurogentec) using the
non-specific or indicated primers (for strand-specific
R T - P C R ) ,a n da n a l y z e db yq PCR using indicated pri-
mers (Kapa Sybr Fast Universal qPCR Kit, Kapa Biosys-
tems, Woburn, MA, USA) (Additional file 9, Table S3).
In strand-specific RT-PCR, reverse transcription is
primed with a gene specific forward or reverse primer
alone, thereby generating cDNA of specifically the anti-
sense or sense strand of the targeted region respectively.
Controls for this assay are reverse transcription or tem-
plate RNA in the absence of any primer. Quantitative
PCR (qPCR) is then performed using forward and
reverse primers, yielding amplicons that represent sense
or antisense transcripts overlapping that region with the
control no primer RT sample values subtracted as back-
ground from the directional RT primed samples.
ChIP
ChIP assays were performed as previously described
[44]. DNA was immunoprecipitated using anti-RNAPII
phosphor-S2 (AbCam no. ab5095, AbCam Cambridge,
MA USA), anti-H3K27me3 (Cell Signaling no. 9756S,
Danvers, MA, USA), or anti-CTCF (Santa Cruz Biotech-
nology no. sc-15914, Santa Cruz, CA, USA) antibody
bound complexes were then pulled down using mag-
netic Dynabeads Protein A (Life Technologies, Carlsbad,
CA, USA). DNA was then recovered by phenol/chloro-
form extraction and analyzed by qPCR using indicated
primers (Additional file 9, Table S3) (Kapa Sybr Fast
Universal qPCR Kit, Kapa Biosystems, Woburn, MA,
USA).
Western blot
Cells were lysed in modified RIPA buffer (25 mM Tris
HCl, pH 7.5, 15 mM NaCl, 1% Nonidet P-40, 1% NaD,
and 0.1% SDS) and separated on a NuPAGE 4% to 12%
BisTris gel (Life Technologies, Carlsbad, CA, USA). Pro-
teins were transferred to a nitrocellulose membrane
which was blocked with 5% milk for 1 h and then incu-
bated overnight at 4°C with anti-p21 (Cell Signaling no.
2946) and anti-glyceraldehyde 3-phosphate dehydrogen-
ase (GAPDH) (Millipore no. MAB374, Billerica, MA,
USA) antibodies. The membrane was then washed (10
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and incubated with an anti-mouse horseradish peroxi-
dase-conjugated secondary antibody for 1 h at room
temperature (Upstate no. 12-349, Billerica, MA, USA).
The membrane was then washed, treated with chemilu-
minescent detection reagent (HyGLO, Denville Metu-
chen, NJ, USA), and exposed to film. Blot density of a
binary image of Figure 5d was calculated using ImageJ.
Results were standardized to GAPDH and expressed as
fractions of control values.
Additional material
Additional file 1: Table S1. Small RNA (sRNA), CCCTC-binding factor
(CTCF) chromatin immunoprecipitation (ChIP)-seq and RNA polymerase II
(RNAPII) ChIP-seq datasets.
‡Data obtained from ENCODE/UCSC and can
be retrieved from the publicly available ENCODE UCSC genome browser
(http://genome.ucsc.edu/ENCODE/) [5,9]. *All data sets with identifiers
beginning with GSE can be found at that the NCBI Gene Expression
Omnibus (http://www.ncbi.nlm.nih.gov/geo/). MCF-7 CTCF ChIP-seq data
can be found in the EBI Array Express Archive (http://www.ebi.ac.uk/
arrayexpress/).
Additional file 2: Figure S1. Enrichment of transcription initiation (ti)
RNAs at sites of conserved CCCTC-binding factor (CTCF) binding
genome-wide. CTCF sites were obtained from the ENCODE Broad
Institute UCSC Histone Mods tracks. Only those with significant peaks
conserved across GM12878, HepG2, HMEC, HSMM, HUVEC, K562, NHEK
and NHLF cell lines were considered in this analysis. (a) Enrichment of
small RNAs at all conserved CTCF sites (gray), and conserved CTCF sites
with evidence of conserved RNA polymerase II (RNAPII) binding in
HUVEC, K562 and NHEK cells (black). (b-d) The size distribution of small
RNAs found at conserved CTCF sites with evidence of RNAPII binding in
(b) THP-1, (c) 5-8f and (d) MCF cells. In (b) and (c) nuclear small RNAs are
shown in black, and cytoplasmic small RNAs are depicted in gray.
Additional file 3: Table S2. Conserved CCCTC-binding factor (CTCF) and
CTCF-RNA polymerase II (RNAPII) site intersection with small RNAs
(sRNAs).
Additional file 4: Figure S2. Enrichment of transcription initiation (ti)
RNAs at sites of subsets of conserved CCCTC-binding factor (CTCF)
binding sites genome-wide. CTCF sites were parsed to (i) exclude any
that mapped within 500 bp of a TSSs or overlapped repeat masker, small
RNA or Ensembl gene annotations less than 300 nucleotides, (ii) into
groups by cell type where ‘cancer’ was derived from MCF-7, K562 and
HepG2 data and normal was derived from GM12878, HUVEC, HMEC,
HSMM, NHEK and NHLF data, and (iii) intersected with the most robust
RNA polymerase II (RNAPII) data for each group (MCF-7 and HUVEC, for
cancer and normal, respectively). Note that tiRNAs are highly enriched at
CTCF-RNAPII sites even in these highly reduced sets.
Additional file 5: Figure S3. The intronic p21 (cyclin-dependent kinase
inhibitor 1A gene, also known as CDKN1A) CCCTC-binding factor-RNA
polymerase II (CTCF-RNAPII) site is highly conserved in mammals. In the
top panel the p21/CDKN1A locus in mouse is shown. The bottom panel
is a focused view of the intronic CTCF-RNAPII site. Note the conserved
CTCF site, RNAPII binding, and high conservation of the site itself and
the sequence immediately to the left (5’ with respect to p21), which is
the site of transcription initiation (ti)RNA biogenesis in humans.
Additional file 6: Figure S4. p21 (cyclin-dependent kinase inhibitor 1A
gene, also known as CDKN1A) CCCTC-binding factor (CTCF) proximal
(cp)-transcription initiation (ti)RNA RNA sponge and mimics effects are
conserved in THP-1 cells. Samples were prepared and analyzed identical
to those shown in Figure 3. Note the increase in p21 mRNA levels in
response to the cp-tiRNA sponge, and the decrease in expression in
response to cp-tiRNA mimics.
Additional file 7: Figure S5. A schematic of the CCCTC-binding factor
(CTCF) sites proximal to C2orf42 and StAR-related lipid transfer domain
containing 13 (STARD13). (a, b) Gene models are shown at the top of
each panel, followed by the collapsed density of small RNAs in three
datasets, CTCF binding density in nine human cell types, and RNA
polymerase II (RNAPII) binding in three human cell lines. In (a) the
conserved C2orf42 CTCF site is approximately 5 kb downstream of the 3’
untranslated region (UTR). The CTCF site in (b) sits approximately halfway
between STARD13 and RFC3.
Additional file 8: Figure S6. The effect of the CCCTC-binding factor
(CTCF) proximal (cp)-transcription initiation (ti)RNA RNA sponge on CTCF
sites proximal to C2orf42. (a) The effects of the C2Orf42 sponge on CTCF
localization. (b) The effects of C2Orf41 tiRNA sponges on mRNA
expression. Experiments were standardized to pCDNA transfected MCF-7
cells. (c) The effects of the C2Orf41 sponge on histone H3 localization.
Samples were analyzed as indicated 72 h post transfection. The averages
of triplicate transfected samples are shown with the error bars
representative of the standard errors of the means, and P values from
paired t tests. (a, c) No antibody values were subtracted from each IP,
and the resultant values were standardized to the input for each sample.
Additional file 9: Table S3. Oligonucleotides used for cloning,
quantitative reverse transcription (qRT)-PCR, and chromatin
immunoprecipitation (ChIP) analysis.
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